T R Elliott1,2,3, B N Hudspith1, N B Rayment1, N J Prescott4, L Petrovska1, J Hermon-Taylor1, J Brostoff1, A Boussioutas3, C G Mathew4, J D Sanderson1,2. 1. Diabetes and Nutritional Sciences Division, King's College London, London, UK. 2. Department of Gastroenterology, Guy's and St. Thomas' NHS Foundation Trust, St Thomas' Hospital, London, UK. 3. Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia. 4. Department of Medical and Molecular Genetics, King's College London School of Medicine, Guy's Hospital London, London, UK.
Abstract
BACKGROUND AND AIM: Escherichia coli can be isolated from lamina propria macrophages in Crohn's disease (CD), and their intramacrophage persistence may provide a stimulus for inflammation. To further determine the contributions of macrophage dysfunction and E. coli pathogenicity to this, we aimed to compare in vitro functioning of macrophages from patients with CD and healthy controls (HC) in response to infection with CD-derived adherent-invasive E. coli (AIEC) and less pathogenic E. coli strains. METHODS: Monocyte-derived macrophages were cultured from patients with CD and HC. Intramacrophage survival of E. coli strains (CD-derived adherent-invasive [AI] and non-AI strains and laboratory strain K-12) was compared. Macrophage cytokine release (tumor necrosis factor alpha [TNFα], interleukin [IL]-23, IL-8 and IL-10) and monocyte phagoctyosis and respiratory burst function were measured after E. coli infection. For CD patients, laboratory data were correlated with clinical phenotype, use of immunomodulation, and CD risk alleles (NOD2, IL-23R, ATG16L1 and IRGM). RESULTS: Attenuated TNFα and IL-23 release from CD macrophages was found after infection with all E. coli strains. There was prolonged survival of CD-derived AIEC, CD-derived non-AIEC and E. coli K-12 in macrophages from CD patients compared to within those from HC. No abnormality of monocyte phagocytosis or respiratory burst function was detected in CD. Macrophage dysfunction in CD was not influenced by phenotype, use of immunomodulation or genotype. CONCLUSIONS: CD macrophage responses to infection with E. coli are deficient, regardless of clinical phenotype, CD genotype or E. coli pathogenicity. This suggests host immunodeficiency is an important contributor to intramacrophage E. coli persistence in CD.
BACKGROUND AND AIM: Escherichia coli can be isolated from lamina propria macrophages in Crohn's disease (CD), and their intramacrophage persistence may provide a stimulus for inflammation. To further determine the contributions of macrophage dysfunction and E. coli pathogenicity to this, we aimed to compare in vitro functioning of macrophages from patients with CD and healthy controls (HC) in response to infection with CD-derived adherent-invasive E. coli (AIEC) and less pathogenic E. coli strains. METHODS: Monocyte-derived macrophages were cultured from patients with CD and HC. Intramacrophage survival of E. coli strains (CD-derived adherent-invasive [AI] and non-AI strains and laboratory strain K-12) was compared. Macrophage cytokine release (tumor necrosis factor alpha [TNFα], interleukin [IL]-23, IL-8 and IL-10) and monocyte phagoctyosis and respiratory burst function were measured after E. coli infection. For CD patients, laboratory data were correlated with clinical phenotype, use of immunomodulation, and CD risk alleles (NOD2, IL-23R, ATG16L1 and IRGM). RESULTS: Attenuated TNFα and IL-23 release from CD macrophages was found after infection with all E. coli strains. There was prolonged survival of CD-derived AIEC, CD-derived non-AIEC and E. coli K-12 in macrophages from CD patients compared to within those from HC. No abnormality of monocyte phagocytosis or respiratory burst function was detected in CD. Macrophage dysfunction in CD was not influenced by phenotype, use of immunomodulation or genotype. CONCLUSIONS: CD macrophage responses to infection with E. coli are deficient, regardless of clinical phenotype, CD genotype or E. coli pathogenicity. This suggests host immunodeficiency is an important contributor to intramacrophage E. coli persistence in CD.
Authors: Timothy R Elliott; Neil B Rayment; Barry N Hudspith; Rebecca E Hands; Kirstin Taylor; Gareth C Parkes; Natalie J Prescott; Liljana Petrovska; John Hermon-Taylor; Jonathan Brostoff; Alex Boussioutas; Christopher G Mathew; Stephen A Bustin; Jeremy D Sanderson Journal: BMC Gastroenterol Date: 2015-07-03 Impact factor: 3.067
Authors: Wilhelmina Maria Cornelia Timmermans; Jan Alexander Michael van Laar; Petrus Martinus van Hagen; Menno Cornelis van Zelm Journal: Clin Transl Immunology Date: 2016-12-16
Authors: Rahul Mittal; Christopher V Lisi; Hansi Kumari; M'hamed Grati; Patricia Blackwelder; Denise Yan; Chaitanya Jain; Kalai Mathee; Paulo H Weckwerth; Xue Z Liu Journal: Front Microbiol Date: 2016-11-18 Impact factor: 5.640
Authors: Lina Y Alkaissi; Martin E Winberg; Stéphanie D S Heil; Staffan Haapaniemi; Pär Myrelid; Eduard F Stange; Johan D Söderholm; Åsa V Keita Journal: Inflamm Bowel Dis Date: 2021-06-15 Impact factor: 5.325